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Introduction
Vaccine hesitancy is defined by the World Health Organization as delay in making a decision
to accept or reject a vaccine, despite the vaccine’s availability (WHO, 2019). It has also been declared
one of the top 10 threats to public health (Szilyagi et al, 2020). There are many factors that come
into play when a patient is choosing whether or not to get vaccinated. Minors are represented by a
guardian who typically makes the decision on vaccines and other health outcomes. Vaccine hesitancy
is seen both in patients as they make their own health decisions and in parents as they decide for
their child. Many factors can contribute to hesitancy or readiness to make these choices, such as
values, education, and potential effects of the vaccine. Today, with the rise of social media, it is even
easier to spread these myths and harder to distinguish fact from fiction. This review will discuss the
human papillomavirus (HPV) vaccine and its association with vaccine hesitancy.
While autonomy is an important part of the healthcare process, the decision to reject
vaccines can have adverse effects. Vaccine hesitancy not only effects the patient in question, but the
whole community around them. Today, populations are able to live without fear of many vaccinepreventable diseases. Even if an individual is not vaccinated, for whatever reason, the number of
vaccinated individuals in their community keeps them mostly protected. This concept is called herd
immunity, and it is important because it protects the people who cannot be vaccinated due to
medical conditions or age. When you add to that number the patients who choose to reject a
vaccine, the significant numbers of unvaccinated individuals means that this safeguard is not there.
The human papillomavirus (HPV) vaccine is administered to adolescents in a series of two
shots, beginning around age 11. This age is recommended because at this point in a child’s life, they
are less likely to have been exposed to the virus (CDC, 2019). Human papillomavirus is very
common, so common that it is expected that almost everyone will be exposed at some point in their
life. The infection itself is not as much of a concern as the cancers it can cause affected individuals

later in life. Every year, over 25,000 cases of HPV-associated cancers are reported, and thousands of
these cases result in deaths (Luisi, 2020). HPV can lead to cancer of the throat, anus, and genital
areas of both men and women. A person becomes infected after skin-to-skin contact or by having
oral, anal, or vaginal sex with someone who is infected (CDC, 2019). Despite these concerns, a study
done in 2018 found that only 54% of girls and 49% of boys in the United States had completed the
HPV vaccine series (Szilyagi et al., 2020).
Factors That Contribute to Vaccine Hesitancy
Vaccine hesitancy is a very complex issue. Patients and guardians must evaluate their vaccine
options against many aspects in their life. In some places, policies are in place that eliminate the need
for the decision process. Certain vaccines are required by employers, groups, or for children to begin
school. While controversial, these policies increase vaccine uptake. When a vaccine is optional, there
are many factors that go into the decision-making process.
Knowledge is a key factor when making vaccine decisions. Researching side effects, efficacy,
and safety of a vaccine is important rather than basing a decision on what is expected. Studies have
shown that parents who reject certain vaccines have typically done more research on the topic than
those who accept them. Parents who refuse a vaccine on behalf of their children, overall, have been
found to have more knowledge and interest in health issues. Knowledge and perceptions of
susceptibility and severity also play a role. Perceived susceptibility refers to how likely someone
believes they are to contract the vaccine-preventable illness. The more susceptible they believe
themselves to be, the more likely they are to become vaccinated. Perceived severity is what an
individual believes will be their outcome if they do contract the disease, and how severe they believe
that to be. Again, the more severe they believe it to be, the more likely they are to accept the vaccine
(Dube et al., 2013). Comprehensive sex education and clear, open communication with healthcare

providers can help increase knowledge and understanding of the risks associated with sexually
transmitted infections, such as HPV.
Beliefs and social influences also play a major role in vaccine hesitancy. Having family
members or peers who are vaccinated and vaccinate their children increases the likelihood that an
individual will do the same. Moral beliefs and values also may play a role. Some cultures and
religions have strong ties to traditional medicine and may prefer traditional preventive methods over
vaccines. Religious groups, such as the Amish in the United States, also express an opposition to
vaccines that contradict their belief systems (Dube et al., 2013).
The HPV vaccine has its own unique set of challenges. First of all, because it is a series,
patients must be willing and able to get two doses, something that can be challenging. Not only must
they be able to access and afford a second dose, but they must also understand the importance of
the second dose. Receiving both doses within a certain time period is also important, which can be
a potential barrier. Another important consideration is the fact that human papillomavirus is a
sexually transmitted infection. This can bring on hesitancy in that parents may fear that by
vaccinating their children, they are sending a message that it is now okay to become sexually active.
This can become a substantial barrier among groups who see sex as a taboo or otherwise may fear
judgment (Bonanni et al., 2017). A final consideration is that with modern medical interventions,
women have pap smears and other preventive care that they may mistakenly believe is sufficient for
cancer prevention (Bednarczyk, 2019).
Common Myths Regarding the HPV Vaccine
A large contributor to vaccine hesitancy is the presence and spread of myths and other false
information. There are many myths and misunderstandings regarding the human papillomavirus
vaccine, in particular, due to its relation to sexual activity and the age at which it is administered.
One myth is that the HPV vaccine itself is not safe. This myth is based on reports of individual

deaths that occurred sometime after receiving the HPV vaccine. After being reported to the CDC,
these deaths were investigated, and no evidence was found connecting the vaccine to the deaths.
Another concern is that being vaccinated will lead to autoimmune disease or cause ovarian failure.
Regarding both concerns, studies showed that neither issue is not caused by the vaccine, and there
was no connection found at all to autoimmune disease development. Other concerns have been
raised regarding insufficient testing of the vaccine before its approval. Upon the US approval of the
HPV vaccine in 2006, there had been many clinical trials done to test safety and effectiveness.
Following this, there continue to be many studies published confirming the safety of the vaccine
(Bednarczyk, 2019).
Others assert that the vaccine is not effective or is not necessary. When first developing the
HPV vaccine, clinical trials were done to monitor subjects for pre-cancers only. This was done
because the cancers that can result from human papillomavirus take years, sometimes even decades,
to develop. This study design led to hesitancy among those who believed that the vaccine had not
actually been shown to prevent cancer. While not proven immediately, with continued monitoring,
researchers have seen the prevalence of HPV-related cancers decrease in those who received the
vaccine. Because the HPV vaccine is linked to prevention of cervical cancers, some hesitant parents
feel that early detection through a pap smear is sufficient, so therefore the vaccine is not necessary.
While it is true that regular pap smears are important for early detection of cervical cancer, they do
not assess for other cancers, such as those of the throat and anus, that can be caused by human
papillomavirus (Bednarczyk, 2019).
A third belief among hesitant parents is that 11 or 12 years of age is too young to vaccinate.
People may believe this for various reasons, but it is commonly asserted that the vaccine could
“wear off” or that getting a child vaccinated sends a message that it is okay to be sexually active at
their age. There has been research done on both of these viewpoints. In clinical trials, researchers

found that when vaccinated at age 15, teens did not have as great of an immune response as their
younger counterparts. This led to the recommended age being lowered, in 2016 (Bednarczyk, 2019).
A study done on 26 girls, ages 11 and 12, focused on the importance of education for preventing
risky sexual behaviors. When first interviewed, many of the girls had a fairly good understanding of
HPV, recognizing that HPV is a sexually transmitted infection and that the vaccine can prevent
certain cancers. Half of the girls studied, however, demonstrated low or inconsistent knowledge
about HPV and the vaccine. Common misconceptions were identified regarding the type of cancer
that is prevented and how HPV is spread. Overall, knowledge and understanding of HPV and its
vaccine increased as the study continued, mainly due to education from a parent or in a school
setting. Girls who had open communication with their mothers about sex and safety had more
knowledge about HPV and other STIs, as well as more accurate risk perception. Most of the girls
interviewed (19 out of 26) had not initiated sexual activity at the time of the second interview (30
months after the first). Of these, 20 reported feeling safer if they were to have sex, but 18 of those
20 agreed that using protection, such as a condom, would still be necessary (Mullins et al., 2015).
This study helps illustrate the point that building a good understanding of safe sexual behaviors with
adolescents is related to safer sex practices and receiving the HPV vaccine does not suddenly cause
urges to partake in risky sexual behaviors.
The Role of Social Media
Social media has been shown to play a crucial role in vaccine hesitancy. A 2016 study analyzed
over 6,000 Facebook posts written since the FDA approval of the HPV vaccine in 2006.
Researchers used search terms such as “HPV vaccine” and “Gardasil” (a brand name for the HPV
vaccine) to search Facebook for posts relating to human papillomavirus and the vaccine. The posts
were sorted by search term used and the year it was posted, then were assessed to determine the
source (individual profile vs. group or public page) and the audience size (number of shares,

reactions, comments). The majority of posts were found to be negative in nature, encouraging the
refusal of HPV vaccines. One page that was discovered, called “CancerTruth,” was responsible for
numerous anti-vaccine posts and had a significant following. One post from the page, written on
March 6, 2014, asserted that 1 of every 912 children who received Gardasil subsequently died. It
went on to say that when compared to the death rate of cervical cancer, 1 out of every 40,000, young
girls are more likely to live if they refuse the vaccine. It contains a link to an article called “The
Murdering of our Daughters.” This post was found to be the most engaging in the study, with over
6,000 comments, 11,000 likes, and 329,000 shares (Luisi, 2020). As of December 31, 2008, VAERS
(Vaccine Adverse Event Reporting System) had received 32 reports of deaths in individuals who had
received the Gardasil vaccine. There was nothing found in any of these cases to suggest that
Gardasil had caused the deaths (FDA, 2009). It has been made clear that this post does not contain
totally factual information, but the message was still spread and likely contributed to vaccine refusal
for many girls.
The study done by Luisi was one of many that reviewed social media posts and their
contribution to vaccine hesitancy. The study found that the more popular posts (those with more
shares, likes, and comments) contained anti-vaccine messages or otherwise negative tones. HPV
vaccine benefits were mentioned in less than 20% of the posts analyzed. It was found that most of
these pro-vaccine posts were made by organizations and group pages, and most of the others were
written by individuals (Luisi, 2020). With a platform such as Facebook, with billions of users who
can post almost anything (there are some guidelines and restrictions, which it is important to note
have developed and increased over the years), it is easy to see how false information can be spread
and get the attention of the masses. Many people will believe statements made by different
individuals or groups without checking their sources or critically analyzing their claims. This plays a

huge role in vaccine hesitancy, as the drastic claims lead people astray, but also promote distrust of
true professionals and experts in the community.
In February 2019, the Western Cape Department of Health in South Africa announced, via
Facebook, their plans to implement a school-based program that would administer the first dose of
the HPV vaccine to 9 year old girls in their public school system. The post received a flood of
reactions. “Hesitant” comments made up 33% of the total responses. These comments ranged from
statements like “I will be sure to keep my children away from that” to more aggressive comments
such as “‘Omg. . . Agenda 21 in full effect. . . come close to my child with this I will hurt you.”
“Agenda 21” was a phenomenon that asserted that the HPV vaccine was part of an attempt to
reduce the population. The more positive, pro-vaccine comments addressed the severity of HPV
related cancers and benefits of being vaccinated (Wiyeh et al., 2019).
There are many ways to quickly spread false information, but with the rise of social media, it is
easier than ever. Studies like these show the spectrum of claims and information that is readily
available on social media. It is important to address these myths and educate the public on them, but
also educate about the importance of critically analyzing sources to discern between fact and fiction.
Interventions
Interventions designed to address HPV vaccine hesitancy have been implemented both in
the vaccine recipient community (girls and parents) and among providers and medical students.
Both are important populations to target, because each has a distinct role in the vaccine decision
process. In fact, physician recommendation has been found to be a contributor to vaccine uptake, as
lack of recommendation has been associated with refusal (Holman et al., 2014).
A study done in Italy assessed overall HPV knowledge and potential sources of both
hesitancy and confidence in the vaccine. Participants were divided into two groups- an intervention
group, who received a questionnaire, and a control group, who did not. The questionnaires were

conducted over the phone, and asked parents and guardians of the girls about human
papillomavirus, the HPV vaccine, and cancers associated with HPV. Among parents surveyed,
31.7% said they trusted the vaccine, and 28% were still hesitant. The majority, 62.3%, reported that
most of their education on the topic came from a healthcare provider, and of those, 44.5% still
believed that they had an inadequate amount of information provided to them. A year after the
questionnaire was administered, a follow-up was done to see how many of the girls had completed
the entire vaccine series. In the control group, 10.3% completed the series, compared to 27.1% in
the intervention group (Palmeri et al., 2017). Despite the low percentage of vaccine uptake in both
groups, the percentage doubles between the control and intervention groups. This study cites
patient-provider communication and overall education as important ways to prevent vaccine
hesitancy.
Another program done regarding patient-provider communication was implemented with
medical students. Because provider recommendation plays such a role in vaccine acceptance or
refusal, the curriculum was designed to provide students with the tools they will need to address the
vaccine in their future practice. A survey done prior to the intervention found that adolescents who
had the HPV vaccine recommended to them by their provider were 5 times as likely to take the
vaccine (Schnaith et al., 2018). When asked, providers reported having low levels of self-efficacy in
addressing the concerns of vaccine-hesitant parents. This intervention, done with 132 medical
students at the University of Minnesota, consisted of a presentation from a physician, a video about
communication strategies, and role-playing simulations (Schnaith et al., 2018). The effectiveness of
the intervention was assessed using pre and post surveys. The results included an increase in overall
feelings of comfort and confidence in speaking with vaccine hesitant parents. There was also an
increase in knowledge of the benefits of HPV vaccination and increased likelihood of
recommending the vaccine to children of both sexes. Prior to the intervention, medical students

reported that they would be more likely to recommend the vaccine to female patients than males,
which illustrates the common misconception that the vaccine is not equally as necessary for males
and females. On top of these findings, the study discovered that key elements of vaccine uptake
included recommendation and strong endorsement by the provider, educational messages about
cancers and prevention, followed by same day vaccination (Schnaith et al., 2018). Both interventions
attempted to increase knowledge relating to the HPV vaccine, in order to reduce hesitancy.
There are many factors that come into play when a patient or guardian chooses to accept or
refuse a vaccine. These include cultural differences, belief systems, socioeconomic status, education
level, insurance status, accessibility, and many more. The most common determinant to be
addressed in interventions was general knowledge relating to the HPV vaccine. The above
interventions used an educational approach, but with two different populations. It has been found
that having both patients and providers who are informed and confident in their knowledge
increases confidence in the vaccine, and vaccine uptake.
Discussion
Hesitancy is seen for all vaccines, but the HPV vaccine has a unique set of challenges that
contribute. First, it requires a series of doses over time. Accessibility and perceptions of finishing the
series can prevent it from happening, leaving the patient with a decreased immunity to the virus.
Second, because HPV is commonly sexually transmitted, the vaccine may not be seen as necessary.
Some may believe that the recommended age is too low, or that it will encourage their children to
begin sexual experimentation. Both are false notions, as stated above.
Along with these, there are many myths that have been spread that also contribute to HPV
vaccine hesitancy. Some believe that the vaccine is not safe or effective, others are more concerned
with the age at which the vaccine is administered and the message that they could be sending by
having their child vaccinated.

The interventions assessed here focused on education as a tool to combat vaccine hesitancy.
These two studies tackled the issue from different perspectives, as one was implemented with
medical students who are soon to become providers, and the other with parents of adolescents who
are eligible to receive the vaccine. It is important to acknowledge the connection between these two
target populations. In the study done by Palmeri, 45% of parents reported that, prior to the
intervention, they had received little to no information about HPV and its vaccine from a healthcare
provider (Palmeri et al., 2017). Schnaith found, through the survey of medical students, there was a
lack of knowledge on their part as well. When paired with a lack of understanding about how to
communicate effectively with hesitant parents, many felt that they would not be likely to
recommend the vaccine or would not provide much information to those who seemed to have
already made their vaccine decision. After receiving education and going through simulations, the
medical students felt more confident recommending the HPV vaccine (Schnaith et al., 2018). These
studies demonstrate the importance of education for both providers and patients.
Conclusion
Vaccines are important tools in disease prevention. They have helped to eradicate diseases
that once were major threats to entire populations. When a high percentage of a population is
vaccinated, and therefore immune, their immunity can protect those who are unable to be
vaccinated. This concept, called herd immunity, relies on those who can become vaccinated. When
those who can access and receive a vaccine still choose to refuse it, this threatens the immunity of
the population. It is for this reason that the increasing prevalence of vaccine hesitancy is being
considered one of today’s greatest threats to public health (Szilyagi et al., 2020).
Human papillomavirus is a very common virus. It is estimated that everyone will encounter
it at some point in their lifetime. By becoming vaccinated, not only does a person avoid being
infected, but they also avoid certain cancers that can occur later in life because of the infection

(CDC, 2019). The HPV vaccine is met with hesitancy for a variety of reasons. On top of concerns
about accessibility and safety, the fact that HPV is often sexually transmitted leads to conflict with
religious and moral beliefs about sex. These combined with the current state of social media and
spread of false information contribute to hesitancy in a large percentage of the population who
should be receiving the vaccine. There are many ways to address this, but one of the most effective
ways is education. Educating patients and providers and fostering communication about the HPV
vaccine can increase uptake. Now, more than ever, vaccine hesitancy is an issue, and by increasing
awareness and eliminating stigmas, we can combat hesitancy surrounding the HPV vaccine and save
lives.
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